(Q34351456)

1 August 2017

1 reference

title

Thrombospondins and tumor angiogenesis (English)

1 reference

1 August 2017

1 reference

1 reference

4

1 reference

1 August 2017

F de Fraipont

1

1 reference

1 August 2017

A C Nicholson

series ordinal

2

1 reference

1 August 2017

J J Feige

series ordinal

3

1 reference

1 August 2017

language of work or name

1 reference

1 September 2001

1 reference

Trends in Molecular Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

7

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

401-407

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

1 August 2017

1 reference

7 January 2021

The functions of thrombospondin-1 and-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Differential expression of thrombospondin 1, 2, and 3 during murine development.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Colocalization of thrombospondin and syndecan during murine development

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The cell biology of thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Metabolism of thrombospondin 2. Binding and degradation by 3t3 cells and glycosaminoglycan-variant Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The evolution of cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The functions of thrombospondin and its involvement in physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Inhibition of angiogenesis by thrombospondin-2

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin in malignant and non-malignant breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Plasma thrombospondin levels in patients with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Plasma thrombospondin levels in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Tumor Vasculature Targeted Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

Matrix-bound thrombospondin promotes angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902102-5

7 January 2021

10.1016/S1471-4914(01)02102-5

Identifiers

DOI

1 reference

release_h3umymamwnb2xpi2ijrgkl727e

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h3umymamwnb2xpi2ijrgkl727e

24 November 2022

mapped directly with Wikidata item

1 reference